Blockade of protein kinase A (PKA) localization augments the trafficking and anti-tumor efficacy of adoptively transferred chimeric antigen receptor-expressing T cells

被引：0
|
作者：
Newick, Kheng
O'Brien, Shaun
Sun, Jing
Kapoor, Veena
Maceyko, Steve
Lo, Albert
Pure, Ellen
Moon, Ed K.
Albelda, Steven M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-B27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B27
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Combinatorial Treatment of "Armed" Oncolytic Adenovirus Expressing Checkpoint Inhibitor and Cytokine with Chimeric Antigen Receptor T-Cells Leads to Superior Anti-Tumor Effects in Head and Neck Cancer
    Shaw, Amanda Rosewell
    Porter, Caroline
    Watanabe, Norihiro
    Tanoue, Kiyonori
    Brenner, Malcolm
    Suzuki, Masataka
    MOLECULAR THERAPY, 2017, 25 (05) : 6 - 7
  • [32] Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
    Chi, Xiaowei
    Yang, Peiwei
    Zhang, Erhao
    Gu, Jieyi
    Xu, Hui
    Li, Mengwei
    Gao, Xinmei
    Li, Xin
    Zhang, Yinan
    Xu, Hanmei
    Hu, Jialiang
    CANCER MEDICINE, 2019, 8 (10): : 4753 - 4765
  • [33] Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma
    Zheng, Long
    Hu, Peisheng
    Wolfe, Brandon
    Gonsalves, Caryn
    Ren, Luqing
    Khawli, Leslie A.
    Kaslow, Harvey R.
    Epstein, Alan L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [34] Young T cells age during a redirected anti-tumor attack: chimeric antigen receptor-provided dual costimulation is half the battle
    Hombach, Andreas A.
    Abken, Hinrich
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [35] CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells
    Chun, Inkook
    Kim, Ki Hyun
    Chiang, Yi-Hao
    Xie, Wei
    Lee, Yong Gu Gu
    Pajarillo, Raymone
    Rotolo, Antonia
    Shestova, Olga
    Hong, Seok Jae
    Abdel-Mohsen, Mohamed
    Wysocka, Maria
    Ballard, Hatcher J.
    Barrett, David M.
    Posey, Avery D.
    Powell, Daniel, Jr.
    Gill, Saar I.
    Schuster, Stephen J.
    Barta, Stefan K.
    Rook, Alain H.
    June, Carl H.
    Ruella, Marco
    BLOOD, 2020, 136
  • [36] Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors
    Yuan, Xingxing
    Sun, Zujun
    Yuan, Qingyun
    Hou, Weihua
    Liang, Qiaoyan
    Wang, Yuxiong
    Mo, Wei
    Wang, Huijie
    Yu, Min
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 34 - 51
  • [37] Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors
    Xingxing Yuan
    Zujun Sun
    Qingyun Yuan
    Weihua Hou
    Qiaoyan Liang
    Yuxiong Wang
    Wei Mo
    Huijie Wang
    Min Yu
    Investigational New Drugs, 2021, 39 : 34 - 51
  • [38] c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
    Kang, Chung Hyo
    Kim, Yeongrin
    Lee, Da Yeon
    Choi, Sang Un
    Lee, Heung Kyoung
    Park, Chi Hoon
    CANCERS, 2021, 13 (22)
  • [39] The efficacy of third generation anti-HER2 chimeric antigen receptor T cells in combination with PD1 blockade against malignant glioblastoma cells
    Shen, Luxi
    Li, Hongzhi
    Bin, Shufang
    Li, Panyuan
    Chen, Jie
    Gu, Haihua
    Yuan, Weihua
    ONCOLOGY REPORTS, 2019, 42 (04) : 1549 - 1557
  • [40] B7-H3 Chimeric Antigen Receptor Modified T Cells Show Potent Anti-Tumor Activity in a Preclinical Model of Glioblastoma
    Chow, Kwong-Hon
    Heitzeneder, Sabine
    Xu, Peng
    Theruvath, Johanna
    Mitra, Siddhartha S.
    Cheshier, Samuel Henry
    Li, Gordon
    Mackall, Crystal
    NEUROSURGERY, 2017, 64 : 272 - 272
12345